Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
HIV-positive people with a higher viral load over a longer period appear more likely to develop hepatocellular carcinoma.
This is according to the large randomized controlled START trial.
In an analysis of the liver health of a cohort of HIV/hep B–coinfected people, one third had significant fibrosis.
Those with greater fibrosis before treating hep C see the greatest benefit.
Researchers believe this genetic mutation protected against the 14th century-bubonic plague.
AZT and ddI were the main drugs associated with liver damage in a new study.
Multiple studies have reached this conclusion, raising concerns about sexually transmitted hep C among gay and bi men who have HIV.
A long-term study of women living with both viruses found a link between accelerated fibrosis progression and perimenopause.
A look at a large cohort of Canadians with HIV and hepatitis C also examined modifiable factors associated with a reduced risk of death.
Regardless of whether individuals have hepatitis B or C, the improvement tends to occur quickly.
A high HIV viral load and a low CD4 count are each independently linked to liver fibrosis progression among those with and without hep C.
For people coinfected with HIV and hepatitis C virus (HCV), waiting to start HCV treatment until they progress through the levels of liver fib...
Black women living with HIV and hepatitis C virus (HCV) are less likely to die of liver disease, compared with white and Latina women coinfect...
Could people coinfected with HIV and hepatitis C virus benefit from Selzentry (maraviroc)? Possibly, according to an important new study
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.